Thu, 2024-06-13 12:00 Statement Destiny Lopez, Acting Co-CEO of the Guttmacher Institute, on the US Supreme Court's Decision in FDA v. AHM
Wed, 2024-06-12 12:00 Statement Testimony of Isaac Maddow-Zimet, Guttmacher Data Scientist, before the U.S. Senate Subcommittee on Federal Courts, Oversight, Agency Action, and Federal Rights
Tue, 2024-06-04 12:00 Statement Testimony of Destiny Lopez Guttmacher Acting Co-CEO before the U.S. Senate Committee on Health, Education, Labor, and Pensions
Fri, 2024-05-31 12:00 Policy Analysis Clear and Growing Evidence That Dobbs Is Harming Reproductive Health and Freedom
Mon, 2024-05-06 12:00 Policy Analysis First Quarter 2024 State Policy Trends: An Evolving Focus of Attacks on Abortion, Youth Access, IVF and More
Fri, 2024-05-03 12:00 Statement Guttmacher Statement at the 57th Session of the UN Commission on Population and Development
Mon, 2024-04-22 12:00 Statement Destiny Lopez, acting co-CEO of the Guttmacher Institute, Calls on the US Supreme Court to Protect Abortion in Emergency Situations
Mon, 2024-03-25 12:00 Statement Guttmacher Leadership Speaks Out Against Attacks on Medication Abortion
Tue, 2024-03-19 12:00 Policy Analysis Medication Abortion Accounted for 63% of All US Abortions in 2023—An Increase from 53% in 2020
Tue, 2024-03-19 12:00 Policy Analysis Despite Bans, Number of Abortions in the United States Increased in 2023